SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
MEDICINES
(NQNM:MDCO Last Sale: 34.08 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (MDCO : $34.08)
$1,806 million Market Cap at September 12, 2013
Employs 460.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
8 Sylvan Way Research Report Earnings Snapshot - Last 10/22/18
Parsippany, NJ 07054 Fact Sheet
Phone: (973) 290-6000 Financial Statements
Peer Comparison
Annual Reports

Clive A. Meanwell, Chmn./CEO/Pres., Glenn Sblendorio, CFO
Acquires, develops and commercializes biopharmaceutical products in late stages of development. IPO at $16 August 7, 2000. Raised $96 million, selling 6 million shares, 21% of the outstanding. Lead Manager: J.P. Morgan. Acquired TARGANTA THERAPEUTICS CORP (TARG) February 25, 2009.
Historical Charts    Technical Analysis
No Historical Data available for MDCO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common MDCO $34.08 $ 0 $33.28 $34.13 1,031,184 $20.04 $37.4 53,007
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $1,806,479

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex